ArticlePloS one2025
Topographic analysis of vascular changes in retrograde trans-synaptic degeneration.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the vascular signatures of retrograde trans-synaptic degeneration (RTSD) on OCT and OCTA, and to assess whether these changes differ from those associated with non-arteritic anterior ischemic optic neuropathy (NAION).
methodsThis retrospective cohort study included 24 eyes with RTSD and 12 eyes with NAION. Retinal regions corresponding to visual field defects were topographically defined and compared with anatomically matched internal control regions from the fellow eye. Structural (peripapillary retinal nerve fibre layer(pRNFL), macular ganglion cell-inner plexiform layer(mGCIPL)) and vascular (peripapillary vessel density(pVD], macular vessel density(mVD)) parameters were calculated as affected-to-control ratios (%). Spearman correlation and ANCOVA were used to evaluate structure-vascular relationships and compare regression slopes between groups.
resultsBoth groups exhibited significant structural and vascular reductions in affected regions. NAION eyes demonstrated greater reductions in pRNFL, pVD, and mVD ratios compared to RTSD (all p < 0.05), while mGCIPL ratios showed a non-statistically significant difference (p = 0.065). The correlation between mGCIPL and mVD was higher in NAION (ρ = 0.815, p = 0.001) than in RTSD (ρ = 0.469, p = 0.021). Age-adjusted ANCOVA with an interaction term demonstrated that the slope of the relationship between structural thinning and vascular loss was significantly more pronounced in NAION (interaction β = -0.75, p = 0.049).
conclusionsRTSD demonstrated relatively modest vascular compromise compared to NAION, which is presumed to reflect secondary changes due to reduced metabolic demand following retrograde neuronal degeneration. Quantitative structure-vascular analysis using RTSD as a reference model may aid in distinguishing secondary degeneration from primary ischemic injury in optic neuropathies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.